Metronidazole 50 mg/mL (250 mg/5 mL) oral suspension
Ingredients
| Ingredient | Role | For 100 mL |
|---|---|---|
| Metronidazole | active | 5 g |
| Sodium carboxymethylcellulose and microcrystalline cellulose | suspending agent | See the study |
| Preservative, sweetener, and pH regulators (see the study) | other | See the study |
| Purified water | vehicle | q.s. to 100 mL |
- Strength
- 50 mg/mL (250 mg/5 mL)
- Starting material
- Metronidazole bulk powder
- Container
- See the study
Amounts are ClinDose's arithmetic from the study's concentration; follow the study for the method.
Storage and beyond-use date
| Storage | BUD | Basis |
|---|---|---|
| Refrigerated | 180 days | Cited stability study. Duration supported by the cited stability study for this formula, container, and storage. |
| Room temperature | 180 days | Cited stability study. Duration supported by the cited stability study for this formula, container, and storage. |
Only the storage conditions the source covers are listed. Use the BUD assistant for other cases. The BUD may not be later than any component's expiration date. Verify against the current official USP chapter.
Ingredient checks
No FDA compounding list or NIOSH flags for the active ingredient.
Source
Baratta F, Zingarelli C, Fanton F, Lamy E, Di Lascio G, Brusa P. Metronidazole Suspension for Paediatric Use in Developing Countries: Formulation, Quality, and Stability. Pharmaceutics. 2025;17(6):787. PMID 40574097. PMC12196289. License: CC BY (checked 2026-11-06). Read the article · DOI
For licensed clinicians. Use with clinical judgment.